Additional file 5 of The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability

Additional file 5: Supplementary Tables S4.1 and S4.2. Percentage of cells with mCherry or GFP fluorescence in the preinjection cellular sample or the subcutaneous tumour samples. Subcutaneous tumour samples from CTRL/RNF144B deficient (Table S4.1) or CTRL/p53 deficient (Table S4.2) MEFs were quantified by flow cytometry depending on their fluorescence signal. Represented are the percentage of mCherry+ cells (CTRL), GFP+ cells (shRNF144B or shTRP53, respectively) and the total number of fluorescent cells (mCherry and GFP cells). Negative cells were discarded as they account for mouse host cells. The percentage of GFP+ cells was calculated over the total population of detected fluorescent cells (mCherry + GFP). The preinjection sample (cellular solution before inoculation into the mice) was also quantified.